Symphony
Symphony Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
0 of 4 strong
Not discussed on this call: fundraise.
The short version
US market: Revenue growth in the current quarter expected due to extended US summer; muted sales in the following two quarters as coolers are seasonal products used mainly in summer. US and China subsidiaries (Bonaire USA and GSK China) expected to maintain good growth in near quarters, especially with robust summer conditions extending the season.
From Symphony's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- US market: Revenue growth in the current quarter expected due to extended US summer; muted sales in the following two quarters as coolers are seasonal products used mainly in summer. Robust summers expected to drive significant sales growth in FY27.
- Mexico: Two consecutive mild summers in FY25 and FY26 led to weak sales; a robust summer anticipated in FY27, likely resulting in significant growth.
- China (GSK): Steady growth expected driven by industrial coolers and exports; momentum to continue based on export order inflows.
- India domestic market: 15% revenue growth seen despite inventory overhang; modern trade and digital channels growing over 100%, with huge scaling potential.
- Australia: Revenue continues to soften; no additional capital planned; maintaining business with efficiencies but no major growth drivers currently.
- Export shipments: Still facing some logistics and geopolitical disruptions, especially in the Middle East, limiting full normalization.
- Overall, growth is expected to be seasonal and region-specific with optimism for FY27 driven by improved weather and demand normalization.
Profitability & Margins
See what Symphony said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Symphony Limited's strategy is **not to deploy any additional capital** in their Australian business.
- Management has **assured shareholders that no further impairment or write-offs** related to past investments will occur.
- The company intends to do whatever can be done in Australia **without additional capital deployment** and will keep investors informed as actions unfold.
- There are **no new product introductions or major changes** planned for the Australian subsidiary; they will continue with their existing approach.
- Overall, **no significant new capital expenditure or strategic investment is planned** in the near term, particularly in the Australian market.
Top-ranked in Consumer Durables
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Symphony said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Export shipments are not fully normalized; the Middle East continues to be impacted by disruptions.
- Geopolitical uncertainties and increased costs have led to muted demand and cautious buyer sentiment.
- Order inflows, especially for exports, remain affected due to these factors.
- USA and China markets are expected to see healthy growth in the current quarter but may be muted afterward due to seasonal and export order factors.
- Mexico experienced two mild summers adversely impacting demand; a robust summer is expected next year which should boost sales.
- Overall, while some recovery and improvement in order execution are anticipated, challenges in key export markets persist, influencing the current order book and pending orders scenario.
Symphony — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹338 Cr, net loss ₹218 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Symphony Ltd's management said in earlier quarters
Others in Consumer Durables this season
- Eureka Forbes Ltd (Q1 FY27)
Investments focused on strengthening in-store presence and sales promoters (A&SP spend increased by 21.4% YoY). Key concall takeaways from Eureka Forbes Ltd's…
- Visdem Technosys (Q1 FY27)
Q1 FY27 sales grew by approximately 40% year-on-year, driven by 15% price escalation and 25% volume growth. Key concall takeaways from Visdem Technosys Ltd's…
- Indigo Paints Ltd (Q1 FY27)
EBITDA margins could fluctuate slightly (±1%), but the focus remains on expanding market share and top line. Key concall takeaways from Indigo Paints Ltd's Q1…
- TTK Prestige Ltd (Q1 FY27)
TTK Prestige has planned a total investment outlay of around INR 500 crores over three years, including both capital expenditure (capex) and operational…
Frequently Asked Questions
What were Symphony Q1 FY27 results?
US market: Revenue growth in the current quarter expected due to extended US summer; muted sales in the following two quarters as coolers are seasonal products used mainly in summer. US and China subsidiaries (Bonaire USA and GSK China) expected to maintain good growth in near quarters, especially with robust summer conditions extending the season.
What is Symphony share price analysis?
Symphony currently shows a below-average growth signal. The stock trades at a P/E of 1081.3 with a market cap of ₹4,206 Cr. Investors should review the full earnings analysis for detailed insights.
Is Symphony planning capital expenditure?
Symphony Limited's strategy is **not to deploy any additional capital** in their Australian business.
Keep Symphony on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.